help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chott, A.
Right arrow Articles by Balk, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chott, A.
Right arrow Articles by Balk, S. P.
(American Journal of Pathology. 1999;155:1271-1279.)
© 1999 American Society for Investigative Pathology

Regular Articles

Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor Receptor

Andreas Chott*{dagger}, Zijie Sun*, Daniel Morganstern*, Jing Pan*, Tong Li*, Martin Susani{dagger}, Isabella Mosberger{dagger}, Melissa P. Upton{ddagger}, Glenn J. Bubley* and Steven P. Balk*

From the Cancer Biology Program,*
Hematology-Oncology Division, the Department of Medicine and the Department of Pathology,{ddagger}
Beth Israel Deaconess Medical Center, Boston, Massachusetts; and the Department of Clinical Pathology,{dagger}
University of Vienna, Vienna, Austria

An important biological feature of prostate cancer (PCa) is its marked preference for bone marrow as a metastatic site. To identify factors that may support the growth of PCa in bone marrow, expression of receptor and nonreceptor tyrosine kinases by androgen-independent PCa bone marrow metastases was assessed. Bone marrow biopsies largely replaced by PCa were analyzed using reverse transcriptase-polymerase chain reaction amplification with degenerate primers that amplified the conserved kinase domain. Sequence analyses of the cloned products demonstrated expression of multiple kinases. Expression of the receptor and nonreceptor tyrosine kinases, {alpha} platelet-derived growth factor receptor and Jak 1, respectively, was confirmed by immunohistochemistry. In contrast, the type 1 insulin-like growth factor receptor, thought to play a role in PCa development, was lost in metastatic PCa. These results implicate several specific growth factors and signaling pathways in metastatic androgen-independent PCa and indicate that loss of the type 1 insulin-like growth factor receptor contributes to PCa progression.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
C. D. McCabe, D. D. Spyropoulos, D. Martin, and C. S. Moreno
Genome-Wide Analysis of the Homeobox C6 Transcriptional Network in Prostate Cancer
Cancer Res., March 15, 2008; 68(6): 1988 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Z. Wang, R. M. Luque, R. D. Kineman, V. H. Ray, K. T. Christov, D. D. Lantvit, T. Shirai, S. Hedayat, T. G. Unterman, M. C. Bosland, et al.
Disruption of Growth Hormone Signaling Retards Prostate Carcinogenesis in the Probasin/TAg Rat
Endocrinology, March 1, 2008; 149(3): 1366 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Jiang, R. A. Borgesi, N. C. McKnight, R. Kaur, C. L. Carpenter, and S. P. Balk
Activation of Nonreceptor Tyrosine Kinase Bmx/Etk Mediated by Phosphoinositide 3-Kinase, Epidermal Growth Factor Receptor, and ErbB3 in Prostate Cancer Cells
J. Biol. Chem., November 9, 2007; 282(45): 32689 - 32698.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Mathew, P. F. Thall, C. D. Bucana, W. K. Oh, M. J. Morris, D. M. Jones, M. M. Johnson, S. Wen, L. C. Pagliaro, N. M. Tannir, et al.
Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases
Clin. Cancer Res., October 1, 2007; 13(19): 5816 - 5824.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. S. de Bono, G. Attard, A. Adjei, M. N. Pollak, P. C. Fong, P. Haluska, L. Roberts, C. Melvin, M. Repollet, D. Chianese, et al.
Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor
Clin. Cancer Res., June 15, 2007; 13(12): 3611 - 3616.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. G. Dolloff, M. R. Russell, N. Loizos, and A. Fatatis
Human Bone Marrow Activates the Akt Pathway in Metastatic Prostate Cells through Transactivation of the {alpha}-Platelet-Derived Growth Factor Receptor
Cancer Res., January 15, 2007; 67(2): 555 - 562.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J.-H. Kim, C. Xu, Y.-S. Keum, B. Reddy, A. Conney, and A.-N. T. Kong
Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with {beta}-phenylethyl isothiocyanate and curcumin
Carcinogenesis, March 1, 2006; 27(3): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. L. Goel, M. Breen, J. Zhang, I. Das, S. Aznavoorian-Cheshire, N. M. Greenberg, A. Elgavish, and L. R. Languino
{beta}1A Integrin Expression Is Required for Type 1 Insulin-Like Growth Factor Receptor Mitogenic and Transforming Activities and Localization to Focal Contacts
Cancer Res., August 1, 2005; 65(15): 6692 - 6700.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. D. Wu, A. Odman, L. M. Higgins, K. Haugk, R. Vessella, D. L. Ludwig, and S. R. Plymate
In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors
Clin. Cancer Res., April 15, 2005; 11(8): 3065 - 3074.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. D. Hofer and M. A. Rubin
Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer
J. Clin. Oncol., February 20, 2005; 23(6): 1332 - 1333.
[Full Text] [PDF]

Home page
 JCOHome page
P. Mathew, I.J. Fidler, and C. Bucana
In Reply:
J. Clin. Oncol., February 20, 2005; 23(6): 1333 - 1334.
[Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. Matsuzaki, M. Canis, C. Vaurs-Barriere, J.L. Pouly, O. Boespflug-Tanguy, F. Penault-Llorca, P. Dechelotte, B. Dastugue, K. Okamura, and G. Mage
DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection
Mol. Hum. Reprod., October 1, 2004; 10(10): 719 - 728.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Mathew, P. F. Thall, D. Jones, C. Perez, C. Bucana, P. Troncoso, S.-J. Kim, I. J. Fidler, and C. Logothetis
Platelet-Derived Growth Factor Receptor Inhibitor Imatinib Mesylate and Docetaxel: A Modular Phase I Trial in Androgen-Independent Prostate Cancer
J. Clin. Oncol., August 15, 2004; 22(16): 3323 - 3329.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Rubinstein, G. Idelman, S. R. Plymate, G. Narla, S. L. Friedman, and H. Werner
Transcriptional Activation of the Insulin-Like Growth Factor I Receptor Gene by the Kruppel-Like Factor 6 (KLF6) Tumor Suppressor Protein: Potential Interactions between KLF6 and p53
Endocrinology, August 1, 2004; 145(8): 3769 - 3777.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P. L. Paris, A. Andaya, J. Fridlyand, A. N. Jain, V. Weinberg, D. Kowbel, J. H. Brebner, J. Simko, J.E. V. Watson, S. Volik, et al.
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors
Hum. Mol. Genet., July 1, 2004; 13(13): 1303 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
H.-S. Lin, G. J. Berry, W. E. Fee Jr, D. J. Terris, and Z. Sun
Identification of Tyrosine Kinases Overexpressed in Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, March 1, 2004; 130(3): 311 - 316.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. Wang, V. L. DeGroff, and S. K. Clinton
Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase
J. Nutr., July 1, 2003; 133(7): 2367 - 2376.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
H. Uehara, S. J. Kim, T. Karashima, D. L. Shepherd, D. Fan, R. Tsan, J. J. Killion, C. Logothetis, P. Mathew, and I. J. Fidler
Effects of Blocking Platelet-Derived Growth Factor-Receptor Signaling in a Mouse Model of Experimental Prostate Cancer Bone Metastases
J Natl Cancer Inst, March 19, 2003; 95(6): 458 - 470.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Ide, D. B. Seligson, S. Memarzadeh, L. Xin, S. Horvath, P. Dubey, M. B. Flick, B. M. Kacinski, A. Palotie, and O. N. Witte
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
PNAS, October 29, 2002; 99(22): 14404 - 14409.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. O. Hellawell, G. D. H. Turner, D. R. Davies, R. Poulsom, S. F. Brewster, and V. M. Macaulay
Expression of the Type 1 Insulin-like Growth Factor Receptor Is Up-Regulated in Primary Prostate Cancer and Commonly Persists in Metastatic Disease
Cancer Res., May 1, 2002; 62(10): 2942 - 2950.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. W. Elmlinger, I. Mayer, D. Schnabel, B. S. Schuett, D. Diesing, G. Romalo, H. A. Wollmann, W. Weidemann, K.-D. Spindler, M. B. Ranke, et al.
Decreased Expression of IGF-II and Its Binding Protein, IGF-Binding Protein-2, in Genital Skin Fibroblasts of Patients with Complete Androgen Insensitivity Syndrome Compared with Normally Virilized Males
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4741 - 4746.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-J. Ko, E. J. Small, F. Kabbinavar, A. Chachoua, S. Taneja, D. Reese, A. DePaoli, A. Hannah, S. P. Balk, and G. J. Bubley
A Multi-Institutional Phase II Study of SU101, a Platelet-derived Growth Factor Receptor Inhibitor, for Patients with Hormone-Refractory Prostate Cancer
Clin. Cancer Res., April 1, 2001; 7(4): 800 - 805.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. E. Damon, S. R. Plymate, J. M. Carroll, C. C. Sprenger, C. Dechsukhum, J. L. Ware, and C. T. Roberts Jr.
Transcriptional Regulation of Insulin-Like Growth Factor-I Receptor Gene Expression in Prostate Cancer Cells
Endocrinology, January 1, 2001; 142(1): 21 - 27.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.